109 related articles for article (PubMed ID: 21796138)
41. Tay-Sachs disease and HEXA mutations among Moroccan Jews.
Kaufman M; Grinshpun-Cohen J; Karpati M; Peleg L; Goldman B; Akstein E; Adam A; Navon R
Hum Mutat; 1997; 10(4):295-300. PubMed ID: 9338583
[TBL] [Abstract][Full Text] [Related]
42. Donor splice site mutation in intron 5 of the HEXA gene in a Turkish infant with Tay-Sachs disease.
Ozkara HA; Akerman BR; Ciliv G; Topçu M; Renda Y; Gravel RA
Hum Mutat; 1995; 5(2):186-7. PubMed ID: 7749419
[No Abstract] [Full Text] [Related]
43. Two novel exonic point mutations in HEXA identified in a juvenile Tay-Sachs patient: role of alternative splicing and nonsense-mediated mRNA decay.
Levit A; Nutman D; Osher E; Kamhi E; Navon R
Mol Genet Metab; 2010 Jun; 100(2):176-83. PubMed ID: 20363167
[TBL] [Abstract][Full Text] [Related]
44. A novel mutation in the HEXA gene specific to Tay-Sachs disease carriers of Jewish Iraqi origin.
Karpati M; Peleg L; Gazit E; Akstein E; Goldman B
Clin Genet; 2000 May; 57(5):398-400. PubMed ID: 10852376
[TBL] [Abstract][Full Text] [Related]
45. In-silico screening and microsecond molecular dynamics simulations to identify single point mutations that destabilize β-hexosaminidase A causing Tay-Sachs disease.
Almanasra A; Havranek B; Islam SM
Proteins; 2021 Nov; 89(11):1587-1601. PubMed ID: 34288098
[TBL] [Abstract][Full Text] [Related]
46. Specificity and sensitivity of hexosaminidase assays and DNA analysis for the detection of Tay-Sachs disease gene carriers among Ashkenazic Jews.
Fernandes MJ; Kaplan F; Clow CL; Hechtman P; Scriver CR
Genet Epidemiol; 1992; 9(3):169-75. PubMed ID: 1387862
[TBL] [Abstract][Full Text] [Related]
47. Molecular basis of hexosaminidase A deficiency and pseudodeficiency in the Berks County Pennsylvania Dutch.
Mules EH; Hayflick S; Dowling CE; Kelly TE; Akerman BR; Gravel RA; Thomas GH
Hum Mutat; 1992; 1(4):298-302. PubMed ID: 1301937
[TBL] [Abstract][Full Text] [Related]
48. Factor XI deficiency in Southern Iran: identification of a novel missense mutation.
Karimi M; Jafari H; Lahsaeizadeh S; Afrasiabi A; Akbari A; Dehbozorgian J; Ardeshiri R; Guella I; Asselta R; Peyvandi F
Ann Hematol; 2009 Apr; 88(4):359-63. PubMed ID: 18758779
[TBL] [Abstract][Full Text] [Related]
49. A chronic GM2 gangliosidosis variant with a HEXA splicing defect: quantitation of HEXA mRNAs in normal and mutant fibroblasts.
Fernandes MJ; Hechtman P; Boulay B; Kaplan F
Eur J Hum Genet; 1997; 5(3):129-36. PubMed ID: 9272736
[TBL] [Abstract][Full Text] [Related]
50. Nonsense-mediated decay of human HEXA mRNA.
Rajavel KS; Neufeld EF
Mol Cell Biol; 2001 Aug; 21(16):5512-9. PubMed ID: 11463833
[TBL] [Abstract][Full Text] [Related]
51. Structural consequences of amino acid substitutions causing Tay-Sachs disease.
Ohno K; Saito S; Sugawara K; Sakuraba H
Mol Genet Metab; 2008 Aug; 94(4):462-468. PubMed ID: 18490185
[TBL] [Abstract][Full Text] [Related]
52. Heterozygosity for the "DN allele" (G533-greater than A) of the beta-hexosaminidase alpha subunit gene identified by direct DNA sequencing in a family with the B1 variant of GM2-gangliosidosis.
Whitley CB; Anderson RA; McIvor RS
Neuropediatrics; 1992 Apr; 23(2):96-101. PubMed ID: 1318511
[TBL] [Abstract][Full Text] [Related]
53. Expanding the spectrum of
Sheth J; Mistri M; Datar C; Kalane U; Patil S; Kamate M; Shah H; Nampoothiri S; Gupta S; Sheth F
Mol Genet Metab Rep; 2014; 1():425-430. PubMed ID: 27896118
[TBL] [Abstract][Full Text] [Related]
54. Screening for Tay-Sachs disease carriers by full-exon sequencing with novel variant interpretation outperforms enzyme testing in a pan-ethnic cohort.
Cecchi AC; Vengoechea ES; Kaseniit KE; Hardy MW; Kiger LA; Mehta N; Haque IS; Moyer K; Page PZ; Muzzey D; Grinzaid KA
Mol Genet Genomic Med; 2019 Aug; 7(8):e836. PubMed ID: 31293106
[TBL] [Abstract][Full Text] [Related]
55. Tay-Sachs Carrier Screening by Enzyme and Molecular Analyses in the New York City Minority Population.
Mehta N; Lazarin GA; Spiegel E; Berentsen K; Brennan K; Giordano J; Haque IS; Wapner R
Genet Test Mol Biomarkers; 2016 Sep; 20(9):504-9. PubMed ID: 27362553
[TBL] [Abstract][Full Text] [Related]
56. Seven novel Tay-Sachs mutations detected by chemical mismatch cleavage of PCR-amplified cDNA fragments.
Akli S; Chelly J; Lacorte JM; Poenaru L; Kahn A
Genomics; 1991 Sep; 11(1):124-34. PubMed ID: 1837283
[TBL] [Abstract][Full Text] [Related]
57. Atypical presentation of late-onset Tay-Sachs disease.
Deik A; Saunders-Pullman R
Muscle Nerve; 2014 May; 49(5):768-71. PubMed ID: 24327357
[TBL] [Abstract][Full Text] [Related]
58. Unusual case of Juvenile Tay-Sachs disease.
Cheema HA; Waheed N; Saeed A
BMJ Case Rep; 2019 Sep; 12(9):. PubMed ID: 31519716
[TBL] [Abstract][Full Text] [Related]
59. Rapid and cost-effective method for the detection of the c.533G>A mutation in the HEXA gene.
Ribeiro D; Duarte AJ; Amaral O
Genet Test Mol Biomarkers; 2011 Mar; 15(3):123-6. PubMed ID: 21204700
[TBL] [Abstract][Full Text] [Related]
60. Cerebellar atrophy and muscle weakness: late-onset Tay-Sachs disease outside Jewish populations.
Steiner KM; Brenck J; Goericke S; Timmann D
BMJ Case Rep; 2016 Mar; 2016():. PubMed ID: 27033294
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
